Economic burden of adult patients with β-thalassaemia major in mainland China

Table 3 Cumulative lifetime direct medical cost of adult patients with β-thalassaemia major

Discount rate (%)	Cumulative lifetime direct medical cost ($)			Cumulative lifetime cost for blood transfusion therapy ($)			Cumulative lifetime cost for iron chelation therapy ($)
Discount rate (%)	Mean	95% CI		Mean	95% CI		Mean	95% CI
0	518,871	293,524	744,217	126,470	63,845	189,095	392,400	229,679	555,121
1	397,129	224,655	569,602	96,797	48,865	144,728	300,332	175,790	424,874
2	309,758	175,230	444,286	75,501	38,115	112,887	234,257	137,115	331,399
3	246,066	139,199	352,933	59,977	30,277	89,676	186,090	108,922	263,258
4	198,905	112,520	285,290	48,481	24,474	72,488	150,424	88,046	212,801
5	163,441	92,458	234,424	39,837	20,111	59,564	123,604	72,348	174,860
6	136,367	77,143	195,592	33,238	16,779	49,697	103,129	60,363	145,895
7	115,394	65,278	165,509	28,126	14,199	42,054	87,268	51,079	123,456
8	98,916	55,957	141,875	24,110	12,171	36,049	74,806	43,785	105,827

ISSN: 1750-1172